Association between Hypomagnesemia, COVID-19, Respiratory Tract and Lung Disease
- PMID: 34733373
- PMCID: PMC8493831
- DOI: 10.2174/1874306402115010043
Association between Hypomagnesemia, COVID-19, Respiratory Tract and Lung Disease
Abstract
The complexity of COVID-19 is also related to the multiple molecular pathways triggered by SARS-CoV-2, which is able to cause type I pneumocyte death, trigger intravascular coagulation, interfere with the renin-angiotensin system, dysregulate iron metabolism, ending with the insurgence of a cytokine storm which may lead to death. Old adults with obesity, hypertension, and diabetes are among the high-risk category groups more prone to SARS-CoV-2 infection. Magnesium has been reported to play a major role both in physiology and in pathology, particularly in elderly people, regulating cytotoxic functions of natural killer (NK) cells and CD8+ T lymphocytes. In spite of the absence of controlled trials, the possibility of magnesium supplementation for supportive treatment in patients with COVID-19 should be encouraged. This could be useful in all phases of the COVID-19 disease.
Keywords: COVID-19; Effects; Lung diseases; Magnesium; Magnesium deficiency; Obesity.
© 2021 Faa et al.
References
-
- Littera R, Campagna M, Deidda S, Angioni G, et al. Human leukocyte antigen complex and other immunogenetic and clinical factors influence susceptibility or protection to SARS-CoV-2 infection and severity of the disease course. The Sardinian Experience. Front. Immunol. 2020;4(11):605688. doi: 10.3389/fimmu.2020.605688. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous